These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10403441)

  • 1. The FLS mouse: a new inbred strain with spontaneous fatty liver.
    Soga M; Kishimoto Y; kawaguchi J; Nakai Y; Kawamura Y; Inagaki S; Katoh K; Oohara T; Makino S; Oshima I
    Lab Anim Sci; 1999 Jun; 49(3):269-75. PubMed ID: 10403441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene.
    Soga M; Hashimoto S; Kishimoto Y; Hirasawa T; Makino S; Inagaki S
    Exp Anim; 2010; 59(4):407-19. PubMed ID: 20660987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
    Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
    Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver.
    Soga M; Kishimoto Y; Kawamura Y; Inagaki S; Makino S; Saibara T
    Cancer Lett; 2003 Jun; 196(1):43-8. PubMed ID: 12860288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
    J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
    Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS; Lammert F; Igolnikov A; Green RM
    Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell mass.
    Oze-Fukai A; Fujisawa T; Sugimoto K; Nojima K; Shindo N; Shimoyoshi S; Yoshikawa Y; Sato Y; Shimomura I; Ikegami H; Rakugi H
    Endocr J; 2009; 56(2):227-34. PubMed ID: 19088402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and strain-specific differences in the development of steatosis in rats.
    Stöppeler S; Palmes D; Fehr M; Hölzen JP; Zibert A; Siaj R; Schmidt HH; Spiegel HU; Bahde R
    Lab Anim; 2013 Jan; 47(1):43-52. PubMed ID: 23467489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of grape extract, green tea extract and L-carnitine improves high-fat diet-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease in mice.
    Kang JS; Lee WK; Yoon WK; Kim N; Park SK; Park HK; Ly SY; Han SB; Yun J; Lee CW; Lee K; Lee KH; Park SK; Kim HM
    Phytother Res; 2011 Dec; 25(12):1789-95. PubMed ID: 21480410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
    Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
    J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-obesity properties of a Sasa quelpaertensis extract in high-fat diet-induced obese mice.
    Kang SI; Shin HS; Kim HM; Hong YS; Yoon SA; Kang SW; Kim JH; Ko HC; Kim SJ
    Biosci Biotechnol Biochem; 2012; 76(4):755-61. PubMed ID: 22484945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.